1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

New Opportunity in 2011 for All Symposium Attendees

2011 International Symposium on Malignant Mesothelioma: Legal Panel for the Cure

Thursday, June 23rd 5:45 – 6:45 pm

Hampton Ballroom

“How long will it take for my case to resolve or settle?”

“What are the steps in the process for filing a suit?”

“What is the average settlement award?”

The 2011 International Symposium on Malignant Mesothelioma presents a unique opportunity to meet with some of the top lawyers in the field of mesothelioma litigation in a very special question and answer session, open to all symposium attendees.

The Legal Panel participants will be representatives from firms participating at the Diamond Level in the Legal Partners for a Cure program:

John Bernard – Simmons Law Firm

Bruce C. Hill – Peter Angelos Law Firm

Robert Komitor – Levy Phillips & Konigsberg

The moderated Q&A session will feature both prepared “commonly asked questions,” and questions from the floor. This will cover all aspects of mesothelioma litigation, legal representation, and settlement and trial processes among others. The participating Legal panelists will not be promoting their firms or services but will be on hand in a collaborative environment to provide answers that can help patients and their families navigate through the often complicated process of mesothelioma litigation.

The Legal Partners for a Cure program was started in 2011 to recognize some of the top firms in theUnited Stateswho support the Mesothelioma Applied Research Foundation and its mission to end the suffering of mesothelioma. No referrals are provided to these firms for their support.

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn